±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 651  |  »Ø¸´: 0

ls_2018

гæ (СÓÐÃûÆø)

[½»Á÷] ÃÀ¹ú¹úÁ¢ÎÀÉúÑо¿Ôº£¨NIH£©¹ú¼ÒÖ×ÁöÖÐÐÄ£¨NCI£©Chengkai DaiʵÑéÊÒÕÐÆ¸²©ºó

ÃÀ¹ú¹úÁ¢ÎÀÉúÑо¿Ôº£¨NIH£©¹ú¼ÒÖ×ÁöÖÐÐÄ£¨NCI£©Chengkai DaiʵÑéÊÒÕÐÆ¸²©ºó
ÈÈÁÒ»¶Ó­ÓÐÐËȤµÄͬÈʼÓÈ룡
Position Title: Elucidation of proteomic instability in cancer and the role of HSF1 in enabling oncogenesis.
Position Description: Dr. Chengkai Dai¡¯s laboratory at the Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), USA has one postdoctoral
fellowship (visiting fellow) position open. The candidates will participate in projects that elucidate proteomic instability of cancer and tumor-associated amyloidogenesis, new phenomena in cancer biology, and investigate the multifaceted pro-oncogenic roles of heat shock factor 1 (HSF1). HSF1, the master transcriptional regulator of the heat-shock or proteotoxic stress, response, plays a critical role in preserving proteomic stability under stress conditions. Contrasting with its dispensability for primary cells, cancerous cells become dependent on HSF1, a phenomenon referred to as ¡°non-oncogene addiction¡±. Revealed by Project Achilles, numerous human cancer cell lines depend on HSF1.
Dr. Dai¡¯s laboratory is conducting interdisciplinary research in the emerging field of proteomic instability of cancer. His recent research reveals that amyloidogenesis, due to disruption of proteome homeostasis, is tumor-suppressive and that HSF1 plays a critical role in repressing amyloidogenesis (Cell. 2015, 160:729-44; Nature Cell Biology. 2016, 18:527-39; Molecular Cell. 2019, 76:546-561; Science Advances. 2020, 6:eabc6871).
Detailed information about Dr. Dai¡¯s research and publications can be accessed at https://ccr.cancer.gov/staff-directory/chengkai-dai. Candidates for the postdoctoral fellowship may have up to 4 years of postdoctoral training experience. NCI offers an outstanding environment for training and career development. Postdoctoral trainees in Dr. Dai¡¯s lab have successfully competed for NCI career transition awards and secured independent faculty positions.
Applications, sent by e-mail to Dr. Dai (chengkai.dai@nih.gov), Phone (301) 846-5227, should consist of a cover letter describing research experience and interests, curriculum vitae, bibliography, and contact information of three references.
Employer Name: Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, NIH, DHHS.
Position Location: National Cancer Institute ¨C Frederick, Frederick, MD 21702
These positions are subject to a background investigation. The NIH is dedicated to building a diverse community in its training and employment programs.
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ls_2018 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 280Çóµ÷¼Á +21 ¹¾ààÏþÏþ 2026-04-02 22/1100 2026-04-04 11:12 by Öí»á·É
[¿¼ÑÐ] 288Çóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó ²ÄÁÏÓ뻯¹¤ +12 ÂåÉñ¸ç¸ç 2026-04-03 12/600 2026-04-04 09:22 by ÓлúСÃñ¹¤
[¿¼ÑÐ] 268Çóµ÷¼Á +8 ÄãºÃtg 2026-04-03 9/450 2026-04-04 05:08 by gswylq
[¿¼ÑÐ] 353Çóµ÷¼Á +5 MayUxw1 2026-04-03 5/250 2026-04-03 21:17 by à£à£à£0119
[¿¼ÑÐ] ¿¼Ñе÷¼Á +3 Draa 2026-04-03 3/150 2026-04-03 17:37 by hgwz7468
[¿¼ÑÐ] Çóµ÷¼Á +4 15064154688 2026-04-03 5/250 2026-04-03 15:07 by zrongyan
[¿¼ÑÐ] 333Çóµ÷¼Á +9 wfh030413@ 2026-04-03 9/450 2026-04-03 14:20 by °¡¿¡£¡
[¿¼ÑÐ] Ò»Ö¾Ô¸Öйú¿ÆÑ§Ôº´óѧ265Çóµ÷¼Á +9 Ìñµ­ye 2026-03-31 10/500 2026-04-03 11:10 by txp1986
[¿¼ÑÐ] »·¾³285·Ö£¬¹ýÁù¼¶£¬Çóµ÷¼Á +9 xhr12 2026-04-02 9/450 2026-04-03 10:23 by »¯Ñ§»¯¹¤Ë¶Ê¿ÕÐÉ
[¿¼ÑÐ] Ò»Ö¾Ô¸°²»Õ´óѧ0817»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Çóµ÷¼Á +14 ÎÒ²»ÊÇÖ»Òò 2026-04-02 15/750 2026-04-03 09:49 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 348Çóµ÷¼Á +11 zzzzyk123 2026-04-01 11/550 2026-04-02 16:52 by Wang200018
[¿¼ÑÐ] 348Çóµ÷¼Á +6 ÎâÑå׿24k 2026-04-02 6/300 2026-04-02 14:07 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] 261ÇóBÇøµ÷¼Á +5 Ã÷×С¤ 2026-04-01 7/350 2026-04-02 11:17 by ×Þξξ
[¿¼ÑÐ] Ò»Ö¾Ô¸9³õÊÔ366 ±¾Ë«·ÇÇóµ÷¼Á +4 ÔËÆøÀ´µÃÈôÓÐËÆÎ 2026-04-02 4/200 2026-04-02 09:56 by guanxin1001
[¿¼ÑÐ] »¯Ñ§¹¤³Ìר˶324·Ö£¬Ò»Ö¾Ô¸Öйú¿óÒµ´óѧÇóµ÷¼Á +7 ¹¢¹¢1314 2026-04-01 7/350 2026-04-02 07:40 by ÉÐË®¸óÖ÷
[¿¼ÑÐ] 309Çóµ÷¼Á +19 Ë­²»ÊÇÉÙÄê 2026-03-29 19/950 2026-04-01 15:47 by jp9609
[¿¼ÑÐ] Çóµ÷¼Á ÉúÎïѧ 377·Ö +6 zzll03 2026-03-31 6/300 2026-03-31 17:33 by ÌÆãå¶ù
[¿¼ÑÐ] Ò»Ö¾Ô¸´óÁ¬Àí¹¤´óѧ£¬»úе¹¤³Ìѧ˶£¬341 +3 Î÷¹ÏÌïµÄÊØÍûÕß 2026-03-30 3/150 2026-03-31 11:08 by asdfzly
[¿¼ÑÐ] ¹þ¶û±õ¹¤Òµ´óѧ²ÄÁÏÓ뻯¹¤×¨Ë¶378Çóµ÷¼Á +3 Ëþ±ÈÎÚ˹ 2026-03-30 3/150 2026-03-30 22:55 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Çóµ÷¼Á +10 ¼Ò¼Ñ¼Ñ¼Ñ¼Ñ¼Ñ 2026-03-29 10/500 2026-03-30 18:34 by 544594351
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û